Jacobio Pharmaceuticals Group Co., Ltd. (Stock code: 01167) disclosed that on 13 November 2025, 72,000 ordinary shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 6.92 to HKD 6.93 per share, for a total consideration of HKD 498,348. The repurchased shares are held as treasury shares.

After the transaction, Jacobio Pharmaceuticals holds 787,062,780 issued shares (excluding treasury shares) and 4,692,300 treasury shares, maintaining a total of 791,755,080 issued shares. The repurchase was conducted under an existing mandate approved on 10 June 2025, which authorized the company to repurchase up to 78,873,528 shares. So far, 1,672,500 shares (representing approximately 0.21205% of the issued shares at the time of the mandate) have been repurchased under this authorization.